BG61967B1 - Метод и средство за профилактика и лечение на заболявания,причинени от ендотоксини - Google Patents

Метод и средство за профилактика и лечение на заболявания,причинени от ендотоксини Download PDF

Info

Publication number
BG61967B1
BG61967B1 BG101288A BG10128897A BG61967B1 BG 61967 B1 BG61967 B1 BG 61967B1 BG 101288 A BG101288 A BG 101288A BG 10128897 A BG10128897 A BG 10128897A BG 61967 B1 BG61967 B1 BG 61967B1
Authority
BG
Bulgaria
Prior art keywords
pharmaceutical agent
agent according
phospholipid
neutral lipid
weight
Prior art date
Application number
BG101288A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG101288A (en
Inventor
Daniel M. Levine
Thomas S. Parker
Albert L. Rubin
Bruce R. Gordon
Stuart D. Saal
Original Assignee
Rogosin Insitute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26965092&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BG61967(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/288,568 external-priority patent/US5506218A/en
Application filed by Rogosin Insitute filed Critical Rogosin Insitute
Publication of BG101288A publication Critical patent/BG101288A/xx
Publication of BG61967B1 publication Critical patent/BG61967B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1275—Lipoproteins; Chylomicrons; Artificial HDL, LDL, VLDL, protein-free species thereof; Precursors thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BG101288A 1994-08-10 1997-03-05 Метод и средство за профилактика и лечение на заболявания,причинени от ендотоксини BG61967B1 (bg)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/288,568 US5506218A (en) 1992-08-12 1994-08-10 Methods useful in endotoxin based therapy
US08/487,459 US5674855A (en) 1992-08-12 1995-06-07 Methods and compositions useful in prophylaxis and therapy of endotoxin related conditions
PCT/US1995/010189 WO1996004916A1 (en) 1994-08-10 1995-08-10 Methods and compositions useful in prophylaxis and therapy of endotoxin related conditions

Publications (2)

Publication Number Publication Date
BG101288A BG101288A (en) 1997-09-30
BG61967B1 true BG61967B1 (bg) 1998-11-30

Family

ID=26965092

Family Applications (1)

Application Number Title Priority Date Filing Date
BG101288A BG61967B1 (bg) 1994-08-10 1997-03-05 Метод и средство за профилактика и лечение на заболявания,причинени от ендотоксини

Country Status (27)

Country Link
US (1) US5674855A (zh)
EP (1) EP0767666B1 (zh)
JP (1) JP3818660B2 (zh)
CN (1) CN1137688C (zh)
AP (1) AP782A (zh)
AT (1) ATE255415T1 (zh)
AU (1) AU703861C (zh)
BG (1) BG61967B1 (zh)
BR (1) BR9508584A (zh)
CA (1) CA2196906C (zh)
CY (1) CY2514B1 (zh)
CZ (1) CZ287614B6 (zh)
DE (1) DE69532239T2 (zh)
DK (1) DK0767666T3 (zh)
ES (1) ES2211915T3 (zh)
FI (1) FI118035B (zh)
HK (1) HK1003709A1 (zh)
HU (1) HUT77605A (zh)
NO (1) NO313786B1 (zh)
NZ (1) NZ292315A (zh)
OA (2) OA11737A (zh)
PL (1) PL182043B1 (zh)
PT (1) PT767666E (zh)
RO (1) RO115782B1 (zh)
RU (1) RU2174839C2 (zh)
SK (1) SK282493B6 (zh)
WO (1) WO1996004916A1 (zh)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6518412B1 (en) 1997-09-29 2003-02-11 Jean-Louis Dasseux Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
US6037323A (en) 1997-09-29 2000-03-14 Jean-Louis Dasseux Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
US6004925A (en) 1997-09-29 1999-12-21 J. L. Dasseux Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
US6046166A (en) 1997-09-29 2000-04-04 Jean-Louis Dasseux Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
AU4105600A (en) * 1999-03-09 2000-09-28 Max-Delbruck-Centrum Fur Molekulare Medizin Therapy and use of compounds in therapy
US20030032674A1 (en) * 2001-08-13 2003-02-13 Hwang Daniel H. Use of unsaturated fatty acids to treat severe inflammatory diseases
BR0310099A (pt) 2002-05-17 2007-03-20 Esperion Therapeutics Inc método para tratar dislipidemia ou uma doença associada com a dislipidemia
ATE358992T1 (de) * 2003-02-05 2007-05-15 Nutricia Nv Enteralpräparat zur vorbeugung gegen bzw. behandlung von sepsis
ATE521355T1 (de) 2004-05-19 2011-09-15 Los Angeles Biomed Res Inst Verwendung eines detergens zur nicht- chirurgischen entfernung von fett
US7754230B2 (en) * 2004-05-19 2010-07-13 The Regents Of The University Of California Methods and related compositions for reduction of fat
US20060127468A1 (en) * 2004-05-19 2006-06-15 Kolodney Michael S Methods and related compositions for reduction of fat and skin tightening
CN101252942B (zh) * 2005-08-29 2010-12-22 赛普斯治疗有限责任公司 用于治疗或预防由革兰氏阳性细菌引起的病症的方法
GB0522942D0 (en) 2005-11-10 2005-12-21 Leigh Steven Dissolution composition
WO2007137400A1 (en) 2006-06-01 2007-12-06 Institut De Cardiologie De Montreal Method and compound for the treatment of valvular stenosis
KR100785656B1 (ko) * 2007-05-14 2007-12-17 재단법인서울대학교산학협력재단 소염제로 사용되는 소디움글리코콜레이트 또는 그 유도체
SI2396017T1 (sl) 2009-02-16 2015-12-31 Cerenis Therapeutics Holding Sa Mimika apolipoproteina A-1
US8101593B2 (en) 2009-03-03 2012-01-24 Kythera Biopharmaceuticals, Inc. Formulations of deoxycholic acid and salts thereof
CA2827643C (en) 2011-02-18 2019-05-07 Kythera Biopharmaceuticals, Inc. Treatment of submental fat
US8653058B2 (en) 2011-04-05 2014-02-18 Kythera Biopharmaceuticals, Inc. Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits
US9023833B2 (en) * 2012-12-18 2015-05-05 Sepsicure, LLC Method for treating sepsis in patients with albumin, cholesterol and HDL levels above minimum thresholds

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4115313A (en) * 1974-10-08 1978-09-19 Irving Lyon Bile acid emulsions
DE2556592C2 (de) * 1975-12-16 1986-10-09 A. Nattermann & Cie GmbH, 5000 Köln Arzneimittelzubereitungen auf Basis öliger Lösungen von Phospholipiden
US4314997A (en) * 1980-10-06 1982-02-09 Edward Shanbrom Purification of plasma protein products
IL63734A (en) * 1981-09-04 1985-07-31 Yeda Res & Dev Lipid fraction,its preparation and pharmaceutical compositions containing same
CA1237671A (en) * 1983-08-01 1988-06-07 Michael W. Fountain Enhancement of pharmaceutical activity
JPS6193111A (ja) * 1984-05-28 1986-05-12 Funayama Seizo 発熱性物質除去方法
US5032585A (en) * 1987-02-17 1991-07-16 Board Of Regents, The University Of Texas System Methods and compositions employing unique mixtures of polar and neutral lipids for surfactant replacement therapy
AU614465B2 (en) * 1989-04-05 1991-08-29 Yissum Research Development Company Of The Hebrew University Of Jerusalem Medicinal emulsions
DE4017979A1 (de) * 1990-06-05 1991-12-12 Meyer Lucas Gmbh & Co Lipid- bzw. phospholipid-zusammensetzungen sowie diese enthaltendes mittel zur behandlung von erkrankungen sowie auf die zellmembrane zurueckzufuehrende stoerungen
BR9201168A (pt) * 1992-04-02 1994-04-12 Zerbini E J Fundacao Microemulsoes usadas como velculo para carregar quimioterapicos as celulas neoplasicas

Also Published As

Publication number Publication date
FI970534A (fi) 1997-02-07
CN1137688C (zh) 2004-02-11
BG101288A (en) 1997-09-30
AP9700921A0 (en) 1997-01-31
BR9508584A (pt) 1997-10-21
DE69532239D1 (de) 2004-01-15
EP0767666B1 (en) 2003-12-03
FI118035B (fi) 2007-06-15
JP3818660B2 (ja) 2006-09-06
SK282493B6 (sk) 2002-02-05
NO970582D0 (no) 1997-02-07
ATE255415T1 (de) 2003-12-15
RO115782B1 (ro) 2000-06-30
CA2196906A1 (en) 1996-02-22
HK1003709A1 (en) 1998-11-06
OA11737A (en) 2005-05-12
NZ292315A (en) 1998-10-28
FI970534A0 (fi) 1997-02-07
US5674855A (en) 1997-10-07
EP0767666A4 (en) 1998-10-07
JPH10504037A (ja) 1998-04-14
AU703861B2 (en) 1999-04-01
CN1158087A (zh) 1997-08-27
RU2174839C2 (ru) 2001-10-20
WO1996004916A1 (en) 1996-02-22
CY2514B1 (en) 2005-12-23
SK17697A3 (en) 1997-09-10
AU3405295A (en) 1996-03-07
CA2196906C (en) 2004-03-02
PT767666E (pt) 2004-04-30
CZ37197A3 (en) 1997-10-15
DK0767666T3 (da) 2004-04-05
PL318593A1 (en) 1997-06-23
AP782A (en) 1999-11-15
NO970582L (no) 1997-04-07
DE69532239T2 (de) 2004-10-21
EP0767666A1 (en) 1997-04-16
PL182043B1 (pl) 2001-10-31
CZ287614B6 (en) 2001-01-17
ES2211915T3 (es) 2004-07-16
OA10598A (en) 2002-07-15
HUT77605A (hu) 1998-06-29
AU703861C (en) 2001-12-20
NO313786B1 (no) 2002-12-02

Similar Documents

Publication Publication Date Title
BG61967B1 (bg) Метод и средство за профилактика и лечение на заболявания,причинени от ендотоксини
US5614507A (en) Protein and peptide free, neutral lipid and phospholipid containing compositions useful in treating endotoxemia
RU2391985C2 (ru) Способ лечения или предотвращения заболеваний, вызванных грамположительными бактериями
US5587366A (en) Compositions useful in prophylaxis and therapy of endotoxin related conditions
KR100372672B1 (ko) 엔도톡신관련질환의예방및치료에유용한조성물및방법
DE3412793A1 (de) Liposomen mit inhalativen allergenen zur behandlung von allergien, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
WO1996014841A1 (en) Antiviral and antitumor pharmaceutical compositions
MXPA97000929A (en) Use and useful compositions in the prophylaxis and therapy of conditions related to endotox
Horlick The serum lipids in atherosclerosis.
JPH0525035A (ja) 皮膚掻痒症治療剤